ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 105

The DLEU2/miR-15a/16-1 Cluster Inhibit Foxp3+ Treg Cells in Salivary Glands of pSS via Targeting Foxp3

Xuan Wang1, Zhenzhen Wu 1, Jincheng Pu 1, Run Feng 1 and Jianping Tang 1, 11. Department of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, Shanghai, China (People's Republic)

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Foxp3 and Treg cell, lncRNA-Dleu2, miR15a/16-1, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Primary Sjögren’s Syndrome (pSS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and lacrimal glands cells form a large part of the lymphocytic infiltrates observed in salivary and lacrimal gland tissues, particularly in the earlier stages of disease, increasing evidence suggests that Treg cells can suppress and control the autoimmune response to protect the body from autoimmune diseases in humans and in animal models . It is also well known that Treg cells play potent roles in the onset and development of SS, but its roles were controversial. This project aimed to claim its role in pSS by investigating ncRNAs related Treg cell.

Methods: Compared to normal controls, we identified the shared and divergent differentially expressed mRNAs (DEmRNAs), miRNAs (DEmiRNAs) and lncRNAs (DElncRNAs) in salivary glands of  pSS and non-pSS sicca cases by RNA-sequencing and bioinformatics analysis. Functional annotation of DEmRNAs were performed. Both cis and trans-target DEmRNAs of DElncRNAs were identified. The target DEmRNAs of DEmiRNAs were identified as well. The DEmiRNA-DEmRNA-DElncRNA interaction network was constructed. QRT-PCR was performed to validate the slected miRNAs, mRNA and lncRNAs in salivary tissues. Dual-Luciferase Report Gene System was used to confirm the target of miRNA. The ratio of Th17 and Treg cells (FOXP3+CD25+ CD4+ T cell) in salivary were identified by flow cytometry.

Results: According to RNA-sequencing, 1523 DEmRNAs, 821 DElncRNAs and 19 DEmiRNAs were detected in salivary gland of pSS group, compared to non-pSS sicca group. 20 DElncRNAs related Treg cell were detected in 20 paired of salivary glands, and lncRNA-Dleu2 was upregulated in pSS salivary gland(p< 0.001) .After the validation by qRT-PCR, the expression of miR15a/miR16-1 cluster was significant up-regulated in salivary glands of pSS patients (p< 0.001), which was negative related with the FOXp3 mRNA, and positive related with lncRNA-DLEU2. According the bioinformatics analysis and references confirmation, miR15a/miR16-1 located in gene of lncRNA- DLEU2, known as a gene cluster. And dual-Luciferase Report Gene System confirmed Foxp3 is the target of miR15a/miR16-1.Flow cytometry confirmed FOXP3+Treg cells were decreased in salivary gland of pSS, which was positive related with the expression of miR15a and miR16-1.

Conclusion: LncRNA- DLEU2-miR15a/miR16-1 might be responsible for the reduced FOXp3+Treg cell in salivary gland of pSS via targeting FOXp3.


Disclosure: X. Wang, None; Z. Wu, None; J. Pu, None; R. Feng, None; J. Tang, None.

To cite this abstract in AMA style:

Wang X, Wu Z, Pu J, Feng R, Tang J. The DLEU2/miR-15a/16-1 Cluster Inhibit Foxp3+ Treg Cells in Salivary Glands of pSS via Targeting Foxp3 [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-dleu2-mir-15a-16-1-cluster-inhibit-foxp3-treg-cells-in-salivary-glands-of-pss-via-targeting-foxp3/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-dleu2-mir-15a-16-1-cluster-inhibit-foxp3-treg-cells-in-salivary-glands-of-pss-via-targeting-foxp3/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology